Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Consumer Discretionary›Textiles›Textiles & Apparels

SKYBIOTECH HEALTHCARE LIMITED

Textiles › Textiles & Apparels
₹116.00
at close · 28 Oct 2026
▲ 0.00 (+0.00%)
ThemesBiotechnology· announced

Latest filings

  1. Compliance certificate for share dematerialization for Sep 2026 quarter · Compliance
  2. 43rd AGM: All 4 resolutions passed with over 99.99 percent majority · Compliance
  3. Trading Window closed for Q2 FY27 results declaration · Compliance
All filings ↓
Ask Nexa about SKYBIOTECH HEALTHCARE LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Rebranded from Kapil Cotex Limited to Skybiotech Healthcare Limited effective 7 November 2025, with its Corporate Identification Number reclassified from L17100 (textiles) to L21001 (pharmaceuticals and healthcare), reflecting a stated pivot into healthcare. On a standalone basis, the original textile business is effectively dormant: standalone revenue from operations was just Rs 1.54 lakh in Q2 FY26 and zero in Q3 FY26. The actual activity sits in subsidiary Skybiotech Life Sciences Pvt Ltd, which contributed Rs 733.69 lakh of income but a loss of Rs 105.72 lakh in FY26. Consolidated FY26 revenue from operations was Rs 709.78 lakh (up 0.65% YoY), with a consolidated net loss of Rs 111.68 lakh, narrower than the Rs 236.89 lakh loss in FY25. Quarterly trends are choppy — consolidated Q2 FY26 revenue of Rs 191.65 lakh collapsed to Rs 96.27 lakh in Q3 FY26. Materials make up 43.6% of revenue, employees 24.8%, and other operating expenses 40.8%.

Operating scale
Subsidiary Skybiotech Life Sciences — FY26 income
Rs 733.69 lakhFY26
Consolidated revenue from operations
Rs 709.78 lakhFY26
Standalone Q2 FY26 revenue from operations
Rs 1.54 lakhQ2 FY26
Consolidated Q3 FY26 revenue from operations
Rs 96.27 lakhQ3 FY26
Total paid-up equity shares
19,15,000 sharesas at 25 Sep 2025 AGM
Promoter group holding
12,15,575 shares (~63.5%)as at 25 Sep 2025 AGM
Who pays it
Not specified in the filings; subsidiary operates in the healthcare/biotech space but no customer details are disclosed.
Biggest cost
Materials at 43.6% of consolidated revenue (Rs 3.09 crore in FY26).
Kind of business
Small BSE-listed shell that has rebranded from textiles to healthcare; revenue is concentrated in a single loss-making subsidiary and has been choppy across recent quarters.
Where it sits
BSE small-cap, scrip code 512036, registered office in Chh. Sambhaji Nagar (Aurangabad), Maharashtra. Reclassified by ROC from textiles (CIN L17100) to pharmaceuticals and healthcare (CIN L21001).
Market Cap
₹22 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
-9.4%·
ROCE (FY26)
ROE -12.1% · margin -16.4%
Leverage
0.91·
Debt / Equity · moderate
Net debt ₹9.01 Cr
Moves on a normal day
3.65%·
Median daily move
Last 165 sessions · the yardstick for filing-day moves
Where it sits among 229 Other Textile Products peersBar = share of peers beaten · tick = industry median · latest reported figures
P/B#144/185
ROCE#197/215
ROE#178/188
Debt / Equity#140/188
EBITDA margin#193/198
Revenue growth#25/192
Profit growth#69/203

Scorecard

Measured from the filed financials, judged against its Other Textile Products peers · as of FY26 — not investment advice

Strengths
Nothing stands out in the filed numbers.
Concerns
Negative returns on capital — −9.4%
#197 of 215 in Other Textile Products on the latest reported figures

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from SKYBIOTECH HEALTHCARE LIMITED's filed financials and exchange disclosures

What does SKYBIOTECH HEALTHCARE LIMITED do?

SKYBIOTECH HEALTHCARE LIMITED is a Textiles & Apparels company listed on BSE.

Is SKYBIOTECH HEALTHCARE LIMITED profitable?

No. Over the trailing twelve months SKYBIOTECH HEALTHCARE LIMITED reported a net loss of ₹1.12 Cr on revenue of ₹7.10 Cr.

Does SKYBIOTECH HEALTHCARE LIMITED pay a dividend?

Not in the latest reported year — SKYBIOTECH HEALTHCARE LIMITED's dividend payout for FY26 was nil.

Is SKYBIOTECH HEALTHCARE LIMITED debt-free?

No. It reported borrowings of ₹8.42 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹9.01 Cr after cash. Debt stands at 0.91× equity. That is higher than 74% of its 188 Other Textile Products peers.

How much does the SKYBIOTECH HEALTHCARE LIMITED share price move in a day?

On a typical session SKYBIOTECH HEALTHCARE LIMITED moves 3.65% — that is the median absolute close-to-close move across its last 165 trading days. MarketPing measures each filing's price reaction against it.

Where can I track SKYBIOTECH HEALTHCARE LIMITED's announcements?

Every NSE and BSE filing by SKYBIOTECH HEALTHCARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.